Siemens Healthineers : Conference call showed no relief on China
>Q1 solid performance, but impacted by China - The Q1 results of Siemens Healthineers were driven by a strong performance of Varian supported not only by a healthy underlying demand for radiation, but also by a comparatively low base in Q1 2023. Imaging had a solid performance impacted by China. Diagnostics showed some top-line stabilisation (2+2% y-o-y) excluding the antigen, which is also a move into the right direction in our view. No relief in China - ...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.